Search

everythinglearnresearchcommunity

for

Search:↓

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Drugs for prostate enlargement and hair loss were not linked to increased risk of depression or suicide.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Onions have compounds that reduce cancer risk and improve antioxidant activity.

Cancer patients with COVID-19 face higher risks due to possible additional infections.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Older age and prostatic hyperplasia in males increase the risk of hemorrhagic cystitis after stem cell transplantation.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

Hormone therapies like birth control pills and spironolactone are safe and effective for treating women's adult acne.

Early balding may be a sign of future prostate problems.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

Normal levels of DHT can reduce belly fat and increase muscle, but too much can lead to hair loss, prostate issues, and possibly heart disease.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

More biopsy cores and MRI before biopsy can improve prostate cancer detection.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Men with low testosterone should be carefully evaluated and monitored before and during treatment.